Correlation of p53 and bcl-2 expression with vascular endothelial growth factor (VEGF), microvessel density (MVD) and clinico-pathological features in colon cancer

Cancer Letters

Volumn 208, Issue 2, 2004, Pages 227-234

  Perrone, G ^a   Vincenzi, B ^a   Santini, D ^a   Verzi A ^a   Tonini, G ^a   Vetrani, A ^b   Rabitti, C ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Angiogenesis; bcl2; p53; Vascular endothelial growth factor

Indexed keywords

BAG 1 PROTEIN; PARAFFIN; PROTEIN P53; VON WILLEBRAND FACTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER TISSUE; COLON CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULATURE; PATHOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 2442502554     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2003.11.032     Document Type: Article

References (40)

1. Weidner N., Folkman J. Tumoral vascularity as a prognostic factor in cancer. Important Adv. Oncol. 1996;167-190
2. Vogelstein B., Kinzler K.W. The multistep nature of cancer. Trends Genet. 91:1993;38-41
3. Knudson A.G. Hereditary cancer, oncogenes, and antioncogenes. Cancer Res. 45:1985;1437-1443
4. Land H., Parada L.F., Weinberg R.A. Cellular oncogenes and multistep carcinogenesis. Science. 222:1983;771-778
5. Faviana P., Boldrini L., Spisni R., Berti P., Galleri D., Biondi R., et al. Neoangiogenesis in colon cancer: correlation between vascular density, vascular endothelial growth factor (VEGF) and p53 protein expression. Oncol. Rep. 9:2002;617-620
6. Chung Y.S., Maeda K., Sowa M. Prognostic value of angiogenesis in gastro-intestinal tumours. Eur. J. Cancer. 32:1996;2501-2505
7. Norton J.A. Tumor angiogenesis. The future is now. Ann. Surg. 22:1995;693-694
8. Ikeda E., Achen M.G., Breier G., Risau W. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J. Biol. Chem. 270:1995;19761-19766
9. Liu L.X., Lu H., Luo Y., Date T., Belanger A.J., Vincent K.A., et al. Stabilization of vascular endothelial growth factor mRNA by hypoxia-inducible factor 1. Biochem. Biophys. Res. Commun. 291:2002;908-914
10. Dameron K.M., Volpert O.V., Tainsky M.A., Bouck N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science. 265:1994;1582-1584
11. Ravi R., Mookerjee B., Bhujwalla Z.M., Sutter C.H., Artemov D., Zeng Q., et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev. 14:2000;34-44
12. Biroccio A., Candiloro A., Mottolese M., Sapora O., Albini A., Zupi G., Del Bufalo D. Bcl-2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression and in vivo angiogenesis in a breast carcinoma line. Fed. Assoc. Soc. Eur. Biol. J. 14:2000;652-660
13. Grunstein J., Roberts W.G., Mathieu-Costello O., Hanahan D., Johnson R.S. Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function. Cancer Res. 59:1999;1592-1598
14. Saito H., Tsujitani S., Ikeguchi M., Maeta M., Kaibara N. Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue. Br. J. Cancer. 78:1998;1573-1577
15. Takahashi Y., Tucker S.L., Kitadai Y., Koura A.N., Bucana C.D., Cleary K.R., Ellis L.M. Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch. Surg. 132:1997;541-546
16. Kang S.M., Maeda K., Onoda N., Chung Y.S., Nakata B., Nishiguchi Y., Sowa M. Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis. Int. J. Cancer. 74:1997;502-507
17. Zhang Z.F., Zeng Z.S., Sarkis A.S., Klimstra D.S., Charytonowicz E., Pollack D., et al. Family history of cancer, body weight, and p53 nuclear overexpression in Duke's C colorectal cancer. Br. J. Cancer. 71:1995;888-893
18. Takahashi Y., Bucana C.D., Cleary K.R., Ellis L.M. p53, Vessel count, and vascular endothelial growth factor expression in human colon cancer. Int. J. Cancer. 79:1998;34-38
19. Bosari S., Moneghini L., Graziani D., Lee A.K., Murray J.J., Coggi G., Viale G. bcl-2 Oncoprotein in colorectal hyperplastic polyps, adenomas, and adenocarcinomas. Hum. Pathol. 26:1995;534-540
20. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med. 324:1991;1-8
21. Graham C.H., Rivers J., Kerbel R.S., Stankiewicz K.S., White W.L. Extent of vascularization as a prognostic indicator in thin (<0.76 mm) malignant melanomas. Am. J. Pathol. 145:1994;510-514
22. Weidner N., Carroll P.R., Flax J., Blumenfeld W., Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol. 143:1993;401-409
23. Ferrara N. The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res. Treat. 36:1995;127-137
24. Folkman J. What is the evidence that tumours are angiogenesis dependent? J. Natl Cancer Inst. 82:1990;4-6
25. Maeda K., Chung Y., Ogawa Y. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer. 77:1996;858-863
26. Ohta Y., Endo Y., Tanaka M., Shimizu J., Oda M., Hayashi Y., et al. Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer. Clin. Cancer Res. 2:1996;1411-1416
27. Takahashi Y., Mai M., Kitadai Y., Bucana C., Cleary K.R., Ellis L.M. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation of human colon cancer. Cancer Res. 55:1995;3964-3968
28. Takebayashi Y., Aklyama S., Yamada K., Akiba S., Aikou T. Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma. Cancer. 78:1996;226-231
29. Banner B.F., Whitehouse R., Baker S.P., Swanson R.S. Tumor angiogenesis in stage II colorectal carcinoma: association with survival. Am. J. Clin. Pathol. 109:1998;733-737
30. Ishigami S.I., Arii S., Furutani M., Niwano M., Harada T., Mizumoto M., et al. Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. Br. J. Cancer. 78:1998;1379-1384
31. Nakata S., Ito K., Fujimori M., Shingu K., Kajikawa S., Adachi W., et al. Involvement of vascular endothelial growth factor and urokinase-type plasminogen activator receptor in microvessel invasion in human colorectal cancers. Int. J. Cancer. 79:1998;179-186
32. Volpert O.V., Dameron K.M., Bouck N. Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity. Oncogene. 14:1997;1495-1502
33. Zhong H., De Marzo A.M., Laughner E., Lim M., Hilton D.A., Zagzag D., et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 59:1999;5830-5835
34. Iervolino A., Trisciuoglio D., Ribatti D., Candiloro A., Biroccio A., Zupi G., Del Bufalo D. Bcl-2 overexpression in human melanoma cells increases angiogenesis through VEGF mRNA stabilization and HIF-1-mediated transcriptional activity. Fed. Am. Soc. Eur. Biol. J. 16:2002;1453-1455
35. Graeber T.G., Osmanian C., Jacks T., Housman D.E., Koch C., Lowe S.W., Giaccia A.J. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature. 379:1996;88-91
36. Pidgeon G.P., Barr M.P., Harmey J.H., Foley D.A., Bouchier-Hayes D.J. Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells. Br. J. Cancer. 85:2001;273-278
37. Lee J.C., Chow N.H., Wang S.T., Huang S.M. Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients. Eur. J. Cancer. 36:2000;748-753
38. Mukhopadhyay D., Tsiokas L., Sukhatme V.P. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res. 55:1995;6161-6165
39. Kieser A., Weich H.A., Brandner G., Marme D., Kolch W. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene. 9:1994;963-969
40. Fernandez A., Udagawa T., Schwesinger C., Beecken W., Achilles-Gerte E., McDonnell T., D'Amato R. Angiogenic potential of prostate carcinoma cells overexpressing bcl-2. J. Natl Cancer Inst. 93:2001;208-213